Since colon cancer tissues are known to express high HDAC activity compared to normal colon tissues, the HDAC inhibitory effect of DHCA was assessed using colon cancer cells both by ex vivo (biochemical assay) and in vitro (cell based assay) methods. This evidence concerns the gene HDAC9 and colonic neoplasm.